Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,028	870	1,567	1,772	2,680	2,600
Market Cap Growth	43.44%	-44.48%	-11.55%	-33.91%	3.10%	37.52%
Enterprise Value	1,213	1,061	1,922	2,264	2,541	2,604
Last Close Price	22.87	18.84	33.74	38.61	60.17	59.84
PE Ratio	-	-	37.35	111.35	63.85	17.86
Forward PE	7.62	7.10	10.23	11.64	15.43	18.33
PS Ratio	1.49	1.24	2.32	2.66	4.95	6.05
PB Ratio	1.36	1.12	1.80	2.29	3.67	4.20
P/TBV Ratio	3.26	2.47	7.01	24.87	-	6.14
P/FCF Ratio	8.78	4.87	11.23	15.38	33.57	66.27
P/OCF Ratio	7.64	4.59	10.13	12.19	21.32	33.75
PEG Ratio	-	0.53	0.53	0.53	0.66	0.59
EV/Sales Ratio	1.72	1.51	2.85	3.40	4.69	6.06
EV/EBITDA Ratio	7.66	6.01	11.80	14.91	21.45	36.46
EV/EBIT Ratio	17.72	10.87	22.01	31.93	28.26	50.55
EV/FCF Ratio	10.36	5.93	13.78	19.66	31.82	66.37
Debt / Equity Ratio	0.83	0.82	0.67	0.99	1.55	0.87
Debt / EBITDA Ratio	3.63	3.33	3.28	4.55	8.54	6.47
Debt / FCF Ratio	5.39	3.57	4.20	6.63	14.14	13.79
Asset Turnover	0.44	0.45	0.42	0.36	0.32	0.41
Inventory Turnover	1.88	2.19	2.60	2.92	2.40	2.88
Quick Ratio	1.79	1.93	3.95	2.63	1.45	2.28
Current Ratio	2.38	2.40	5.24	3.37	1.66	2.57
Return on Equity (ROE)	-15.57%	-12.08%	5.10%	2.11%	6.22%	29.86%
Return on Assets (ROA)	2.69%	3.90%	3.35%	2.36%	3.36%	3.06%
Return on Capital (ROIC)	2.93%	4.25%	3.65%	2.61%	3.72%	3.45%
Return on Capital Employed (ROCE)	5.60%	7.80%	5.90%	4.60%	5.80%	5.00%
Earnings Yield	-12.40%	-11.45%	2.68%	0.90%	1.57%	5.60%
FCF Yield	11.39%	20.55%	8.90%	6.50%	2.98%	1.51%
Buyback Yield / Dilution	15.61%	11.03%	-11.69%	-1.99%	-4.46%	-5.22%

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q